BAL PHARMA Q3 FY24 Results
BAL PHARMA has released its financial results for the Q3 quarter of Financial Year 23-2024. Here's a comprehensive breakdown of the company's performance:
Revenue Analysis
- Current Quarter Revenue: Rs. 81.66 Cr
- Quarter-on-Quarter (QoQ) Change: -11.76% (Previous Quarter: Rs. 92.54 Cr )
- Year-on-Year (YoY) Change: 6.58% (Same Quarter Last Year: Rs. 76.62 Cr )
Profitability Metrics
- Net Profit: Rs. 0.85 Cr
- QoQ Profit Change: -12.40% (Previous Quarter: Rs. 0.97 Cr )
- YoY Profit Change: 43.54% (Same Quarter Last Year: Rs. 0.59 Cr )
Shareholder Returns
- Earnings Per Share (EPS): Rs. 0.54
- QoQ EPS Change: -12.90% (Previous Quarter: Rs. 0.62)
- YoY EPS Change: 42.11% (Same Quarter Last Year: Rs. 0.38)
Performance Summary
Excellent
BAL PHARMA did very well, with profits growing faster than sales. This means they're managing costs better.
This analysis provides a snapshot of BAL PHARMA's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.
Disclaimer:
This information is for informational purposes only. Please reverify all details from official sources before making any financial decisions. The accuracy and completeness of this data cannot be guaranteed.